mhurhangee/patent-ind-claim-en huggingface dataset:
A method for segregating rejects occurring in the production of extruded plates , in particular panels for covering a surface of a room, wherein an extrudate of an extruder is fed to a calender having several thermoregulated calender rolls , an actual temperature of at least one calender roll is measured, the actual temperature is compared to a target temperature for this calender roll and, in the case that a difference between the actual temperature and the target temperature is outside a predefined tolerance value, a part of an, in particular endless, semi-finished product leaving the calender is segregated as rejects . an extrudate of an extruder is fed to a calender having several thermoregulated calender rolls , an actual temperature of at least one calender roll is measured, the actual temperature is compared to a target temperature for this calender roll and, in the case that a difference between the actual temperature and the target temperature is outside a predefined tolerance value, a part of an, in particular endless, semi-finished product leaving the calender is segregated as rejects .
A cell line comprising: - an endogenous dehydroorotate dehydrogenase (DHODH) gene which is partially or fully inactivated, and - an endogenous glutamine synthetase (GS) gene which is partially or fully inactivated. - an endogenous dehydroorotate dehydrogenase (DHODH) gene which is partially or fully inactivated, and - an endogenous glutamine synthetase (GS) gene which is partially or fully inactivated.
Vaporiser head for an inhaler , in particular for an electronic cigarette product, comprising - a heating element-wick structure assembly having an electrically operable heating element , which has at least one liquid-conducting through-channel and a porous and/or capillary wick structure arranged at an inlet side of the heating element , and - a support plate for retaining the heating element-wick structure assembly , characterised in that - the vaporiser head has a liquid-conducting cannula having a piercing region preferably protruding, wherein - the piercing region is designed for piercing an external component, in particular a liquid reservoir . - a heating element-wick structure assembly having an electrically operable heating element , which has at least one liquid-conducting through-channel and a porous and/or capillary wick structure arranged at an inlet side of the heating element , and - a support plate for retaining the heating element-wick structure assembly , characterised in that - the vaporiser head has a liquid-conducting cannula having a piercing region preferably protruding, wherein - the piercing region is designed for piercing an external component, in particular a liquid reservoir .
A medical inserting apparatus, comprising: a screw nail which is adapted to be inserted into a human body; a driver which allows to insert the screw nail into the human body; a current generator disposed in the driver to generate a predetermined current; a current meter disposed in the driver to measure the current; and a conductor element disposed in the screw nail and the driver along a lengthwise direction and including an exposed portion (S) which is exposed to outside, wherein the conductor element includes a forward conductor element connected to the current generator to allow the current generated by the current generator to flow into the human body, and a reverse conductor element having one end electrically connected to the forward conductor element and the other end connected to the current generator , and including a resistor and the current meter installed to allow the current generated by the current generator to flow to the current meter by current division with resistance of the human body, characterized in that the resistor is a variable resistor , wherein the medical inserting apparatus is adapted to calculate a resistance value of the human body tissue into which the current flowed through the amount of current measured by the current meter and the resistance value of the variable resistor , and to identify a type of the tissue by comparing the calculated resistance value and an inherent resistance value of the tissue. a screw nail which is adapted to be inserted into a human body; a driver which allows to insert the screw nail into the human body; a current generator disposed in the driver to generate a predetermined current; a current meter disposed in the driver to measure the current; and a conductor element disposed in the screw nail and the driver along a lengthwise direction and including an exposed portion (S) which is exposed to outside, wherein the conductor element includes a forward conductor element connected to the current generator to allow the current generated by the current generator to flow into the human body, and a reverse conductor element having one end electrically connected to the forward conductor element and the other end connected to the current generator , and including a resistor and the current meter installed to allow the current generated by the current generator to flow to the current meter by current division with resistance of the human body, characterized in that the resistor is a variable resistor , wherein the medical inserting apparatus is adapted to calculate a resistance value of the human body tissue into which the current flowed through the amount of current measured by the current meter and the resistance value of the variable resistor , and to identify a type of the tissue by comparing the calculated resistance value and an inherent resistance value of the tissue.
A system for forming a composite part with an imprinted feature , the system comprising: a layup mandrel that includes: (i) a mandrel body that defines a layup surface that defines a layup surface finish roughness; and (ii) a plurality of regions of isotropic surface finish spaced-apart on the layup surface , wherein each region of isotropic surface finish of the plurality of regions of isotropic surface finish defines an isotropic surface finish roughness that is greater than the layup surface finish roughness, and further wherein a location of each region of isotropic surface finish corresponds to a desired location for a fastener hole within the composite part . (i) a mandrel body that defines a layup surface that defines a layup surface finish roughness; and (ii) a plurality of regions of isotropic surface finish spaced-apart on the layup surface , wherein each region of isotropic surface finish of the plurality of regions of isotropic surface finish defines an isotropic surface finish roughness that is greater than the layup surface finish roughness, and further wherein a location of each region of isotropic surface finish corresponds to a desired location for a fastener hole within the composite part .
A method of calculating a distance between a first and second base station in a cellular communications network , the method comprising the steps of: a first base station periodically measuring (S1) a power of received signals from a second base station ; characterized by : the first base station identifying (S7) a first and second most frequent power of received signals in the periodic measurements; and the first base station determining (S9) a distance to the second base station based on: the identified first and second most frequent power, an assumed path loss model relating distance between base stations, transmission power at the second base station, and received power at the first base station for a particular propagation environment, and a ratio of the second base station's transmission power at a first transmission setting to its transmission power at a second transmission setting; the first base station determining the distance to the second base station by solving, for distance, the path loss model. a first base station periodically measuring (S1) a power of received signals from a second base station ; characterized by : the first base station identifying (S7) a first and second most frequent power of received signals in the periodic measurements; and the first base station determining (S9) a distance to the second base station based on: the first base station identifying (S7) a first and second most frequent power of received signals in the periodic measurements; and the first base station determining (S9) a distance to the second base station based on: the identified first and second most frequent power, an assumed path loss model relating distance between base stations, transmission power at the second base station, and received power at the first base station for a particular propagation environment, and a ratio of the second base station's transmission power at a first transmission setting to its transmission power at a second transmission setting; the first base station determining the distance to the second base station by solving, for distance, the path loss model.
A method of producing a human pancreas scaffold comprising (i) mechanically damaging the cells in healthy or pathological human pancreas tissue comprising a whole pancreas or a functional unit thereof, (ii) subjecting the cells in the tissue to osmotic stress by exposing the tissue to a hypotonic reagent or hypertonic reagent, (iii) optionally exposing the tissue to a protease and/or DNAase, (iv) exposing the tissue to a detergent, and (v) repeating each of step (ii), step (iii) and step (iv) one or more times in any order, thereby producing a human pancreas scaffold, wherein the human pancreas tissue is subjected to flow shear stress generated by perfusing the human pancreatic tissue in a retrograde direction during steps (ii) to (v) at a rate which is progressively increased to a maximum value over two or more repeats of steps (ii) to (iv) and then maintained. (i) mechanically damaging the cells in healthy or pathological human pancreas tissue comprising a whole pancreas or a functional unit thereof, (ii) subjecting the cells in the tissue to osmotic stress by exposing the tissue to a hypotonic reagent or hypertonic reagent, (iii) optionally exposing the tissue to a protease and/or DNAase, (iv) exposing the tissue to a detergent, and (v) repeating each of step (ii), step (iii) and step (iv) one or more times in any order, thereby producing a human pancreas scaffold, wherein the human pancreas tissue is subjected to flow shear stress generated by perfusing the human pancreatic tissue in a retrograde direction during steps (ii) to (v) at a rate which is progressively increased to a maximum value over two or more repeats of steps (ii) to (iv) and then maintained. thereby producing a human pancreas scaffold, wherein the human pancreas tissue is subjected to flow shear stress generated by perfusing the human pancreatic tissue in a retrograde direction during steps (ii) to (v) at a rate which is progressively increased to a maximum value over two or more repeats of steps (ii) to (iv) and then maintained.
A cone crusher comprising a frame having a top shell assembly and a bottom shell assembly , and a crusher main shaft slidably supported by the frame ; the top shell assembly comprising a spider assembly having a central hub for receiving a top end of the main shaft of the crusher ; the bottom shell assembly comprising a hydraulically operated piston assembly configured to raise and/or lower the main shaft with respect to the frame ; the top shell assembly further comprising a first crush surface ; the crusher further comprising a crusher head assembly supported by the main shaft , the crusher head assembly comprising a second crush surface , wherein the first and second crush surfaces define therebetween a crushing chamber and an opening through which material leaves the crushing chamber when the crusher is in use, characterized in that the crusher further comprises an adjustment arrangement configured to adjust the position of the first crush surface .
Hearing device , which comprises a battery module , - wherein the battery module comprises a secondary cell , - wherein the battery module comprises a reception coil for contactless charging of the secondary cell , - wherein the battery module comprises a circuit board having a conductor track which forms the reception coil , - wherein the circuit board comprises a plurality of layers , which are stacked above one another in a stack direction, - wherein the conductor track extends over the plurality of layers while comprising a conductor loop , which has at least one turn , in each of the plurality of layers , - wherein the secondary cell is cylindrical and has a lateral surface , - wherein the secondary cell extends in a longitudinal direction along a longitudinal axis (L), - wherein the lateral surface encircles the longitudinal axis (L) and bounds the secondary cell in a radial direction (R) perpendicular to the longitudinal direction, characterized - in that the circuit board as well as the reception coil are curved and follow the lateral surface , - in that the circuit board has a curved profile, in such a way that the circuit board is likewise curved around the longitudinal axis (L) of the secondary cell and the stack direction (S) of the circuit board therefore corresponds to the radial direction (R) . - wherein the battery module comprises a secondary cell , - wherein the battery module comprises a reception coil for contactless charging of the secondary cell , - wherein the battery module comprises a circuit board having a conductor track which forms the reception coil , - wherein the circuit board comprises a plurality of layers , which are stacked above one another in a stack direction, - wherein the conductor track extends over the plurality of layers while comprising a conductor loop , which has at least one turn , in each of the plurality of layers , - wherein the secondary cell is cylindrical and has a lateral surface , - wherein the secondary cell extends in a longitudinal direction along a longitudinal axis (L), - wherein the lateral surface encircles the longitudinal axis (L) and bounds the secondary cell in a radial direction (R) perpendicular to the longitudinal direction, - in that the circuit board as well as the reception coil are curved and follow the lateral surface , - in that the circuit board has a curved profile, in such a way that the circuit board is likewise curved around the longitudinal axis (L) of the secondary cell and the stack direction (S) of the circuit board therefore corresponds to the radial direction (R) .
A spar cap connection piece for a wind turbine blade comprising a pre-cured composite component comprising uniaxial fibre running along the length of the component from a first end to a second end in a longitudinal direction corresponding, in use, to the longitudinal direction of the spar to which it is fixed, the first and second ends being inclined in the same sense to the longitudinal direction each at a respective acute angle; the connection piece having a transition region in which the cross-sectional shape of the connection piece transitions from one form to another along the transition region so that, in use, it is able to connect two spar caps having a different cross-sectional shape, characterized in that the connection piece transitions from a curved profile in cross-section at one end to a flat profile in cross-section at the opposite end.
A composite material comprising: a primary phase which is an alloy comprising a metallic element M and a nonmetallic element X and of which at least a portion is an amorphous phase in an amount of 50 vol % or more based on the entire region of the primary phase; and a secondary phase which is dispersed in the primary phase and comprises a crystalline ceramic compound, the ceramic compound consisting of the metallic element M and the nonmetallic element X and represented by M a X b where a and b are each greater than 0, wherein the metallic element M comprises at least one selected from the group consisting of Fe, Cr, Mo, Ni, Co, Cu, Ti, V, Nb, Ta, W, Mn and Al, and the nonmetallic element X comprises at least one selected from the group consisting of Si, B, C, N, S and P, and wherein the secondary phase in the composite material has a distribution density of 0.2 phase/μm to 1.2 phase/μm, as measured by using an electron microscope. a primary phase which is an alloy comprising a metallic element M and a nonmetallic element X and of which at least a portion is an amorphous phase in an amount of 50 vol % or more based on the entire region of the primary phase; and a secondary phase which is dispersed in the primary phase and comprises a crystalline ceramic compound, the ceramic compound consisting of the metallic element M and the nonmetallic element X and represented by M a X b where a and b are each greater than 0, wherein the metallic element M comprises at least one selected from the group consisting of Fe, Cr, Mo, Ni, Co, Cu, Ti, V, Nb, Ta, W, Mn and Al, and the nonmetallic element X comprises at least one selected from the group consisting of Si, B, C, N, S and P, and wherein the secondary phase in the composite material has a distribution density of 0.2 phase/μm to 1.2 phase/μm, as measured by using an electron microscope.
Use of the benzotriazole derivative (a) corresponding to the formula wherein R 1 is hydrogen; C 1 -C 5 alkyl; C 1 -C 5 alkoxy; or halogen; R 2 is hydrogen; C 1 -C 20 alkyl; C 1 -C 5 alkoxy; C 1 -C 5 alkoxycarbonyl; C 5 -C 10 cycloalkyl; C 5 -C 10 aryl; or C 5 -C 10 aralkyl; R 3 is C 1 -C 20 alkyl; C 5 -C 10 cycloalkyl; C 1 -C 20 alkoxy; or C 5 -C 10 cycloalkoxy; and R 4 is hydrogen; or C 1 -C 5 alkyl; for photo-stabilizing cosmetic formulations comprising at least one of the UV filters (c 6 ) Ethylhexyl Methoxycinnamate; and (b 1 ) a compound of formula R 1 is hydrogen; C 1 -C 5 alkyl; C 1 -C 5 alkoxy; or halogen; R 2 is hydrogen; C 1 -C 20 alkyl; C 1 -C 5 alkoxy; C 1 -C 5 alkoxycarbonyl; C 5 -C 10 cycloalkyl; C 5 -C 10 aryl; or C 5 -C 10 aralkyl; R 3 is C 1 -C 20 alkyl; C 5 -C 10 cycloalkyl; C 1 -C 20 alkoxy; or C 5 -C 10 cycloalkoxy; and R 4 is hydrogen; or C 1 -C 5 alkyl; for photo-stabilizing cosmetic formulations comprising at least one of the UV filters (c 6 ) Ethylhexyl Methoxycinnamate; and (b 1 ) a compound of formula
A respiratory system comprising: an adaptor including a sealing portion , a coupling surface , an inlet port , and an outlet port ; a patient interface , coupled to the coupling surface ; and a nozzle , wherein the nozzle comprises: a body comprising a first end and a second end , the first end configured to couple with a medicament delivery device; and a ledge , the nozzle configured to be inserted into the sealing portion of the adaptor such that the ledge rests on the sealing portion of the adaptor ; characterized in that the second end of the body opens near the first end of the coupling surface of the adaptor upon insertion of the nozzle into the adaptor , and the coupling surface is in use coupled to the patient interface at the second end of the coupling surface . an adaptor including a sealing portion , a coupling surface , an inlet port , and an outlet port ; a patient interface , coupled to the coupling surface ; and a nozzle , wherein the nozzle comprises: a body comprising a first end and a second end , the first end configured to couple with a medicament delivery device; and a ledge , the nozzle configured to be inserted into the sealing portion of the adaptor such that the ledge rests on the sealing portion of the adaptor ; characterized in that the second end of the body opens near the first end of the coupling surface of the adaptor upon insertion of the nozzle into the adaptor , and the coupling surface is in use coupled to the patient interface at the second end of the coupling surface . a body comprising a first end and a second end , the first end configured to couple with a medicament delivery device; and a ledge , the nozzle configured to be inserted into the sealing portion of the adaptor such that the ledge rests on the sealing portion of the adaptor ; characterized in that the second end of the body opens near the first end of the coupling surface of the adaptor upon insertion of the nozzle into the adaptor , and the coupling surface is in use coupled to the patient interface at the second end of the coupling surface .
An oral pharmaceutical composition comprising: a) a pharmaceutically acceptable surface-modified acidic medicinal auxiliary material, wherein the pharmaceutically acceptable surface-modified acidic auxiliary material is a powder and comprises an acidic medicinal auxiliary material and a neutral salt layer on a surface of the acidic medicinal auxiliary material, wherein the neutral salt layer comprises an anion of the acidic medicinal auxiliary material and a cation of an alkaline substance for modification, wherein the acidic medicinal auxiliary material is tartaric acid, fumaric acid, succinic acid, citric acid, lactic acid, or malic acid, and wherein the alkaline substance for modification is a hydroxide salt, water-soluble alkaline carbonate or water-soluble alkaline phosphate; and b) ethyl 3-[(2-{4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate that is also called as dabigatran etexilate, or a pharmaceutically acceptable salt or hydrate thereof. a) a pharmaceutically acceptable surface-modified acidic medicinal auxiliary material, wherein the pharmaceutically acceptable surface-modified acidic auxiliary material is a powder and comprises an acidic medicinal auxiliary material and a neutral salt layer on a surface of the acidic medicinal auxiliary material, wherein the neutral salt layer comprises an anion of the acidic medicinal auxiliary material and a cation of an alkaline substance for modification, wherein the acidic medicinal auxiliary material is tartaric acid, fumaric acid, succinic acid, citric acid, lactic acid, or malic acid, and wherein the alkaline substance for modification is a hydroxide salt, water-soluble alkaline carbonate or water-soluble alkaline phosphate; and wherein the neutral salt layer comprises an anion of the acidic medicinal auxiliary material and a cation of an alkaline substance for modification, wherein the acidic medicinal auxiliary material is tartaric acid, fumaric acid, succinic acid, citric acid, lactic acid, or malic acid, and wherein the alkaline substance for modification is a hydroxide salt, water-soluble alkaline carbonate or water-soluble alkaline phosphate; and b) ethyl 3-[(2-{4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate that is also called as dabigatran etexilate, or a pharmaceutically acceptable salt or hydrate thereof.
A method for manufacturing a metal foam comprising a step of sintering a structure comprising a metal component and an organic binder, wherein the metal component comprises a conductive metal having a relative magnetic permeability of 90 or more in an amount of 30% by weight or more, wherein the organic binder is alkyl cellulose, polyalkylene carbonate, polyvinyl alcohol, polyalkylene oxide or polyvinyl acetate, wherein the structure comprises 50 to 400 parts by weight of the organic binder relative to 100 parts by weight of the metal component, wherein the sintering of the structure is performed by applying an electromagnetic field to said structure and wherein the electromagnetic field is formed by applying a current in a range of 100 A to 1,000 A at a frequency in a range of 100 kHz to 1000 kHz.